Carolyn Majcher, OD
Optometrist · San Antonio, TXNPI 1033407127
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Astellas Pharma US Inc at 39.2% of the total. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $499.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$34K
- Carl Zeiss Meditec, Inc.$30K
- Regeneron Healthcare Solutions, Inc.$10K
- Genentech USA, Inc.$4K
- Regeneron$3K
- Apellis Pharmaceuticals, Inc.$2K
- plus $4K from 15 others
Across 1 payment — averaging $1828.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2K
What the payments were for
- Consulting fees$29,44134%
- Speaking & faculty fees$45,70053%
- Travel & lodging$5,9737%
- Food & beverage$5,2106%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 31 | $33,859 |
| Carl Zeiss Meditec, Inc. | 66 | $30,385 |
| Regeneron Healthcare Solutions, Inc. | 22 | $9,624 |
| Genentech USA, Inc. | 6 | $3,836 |
| Regeneron | 6 | $2,731 |
| Apellis Pharmaceuticals, Inc. | 6 | $2,367 |
| Carl Zeiss Meditec USA, Inc. | 8 | $1,587 |
| Topcon Healthcare, Inc. | 2 | $758 |
| Genentech, Inc. | 4 | $291 |
| Tarsus Pharmaceuticals, Inc. | 2 | $194 |
| AbbVie(2 entities) | 5 | $111 |
| LKC Technologies, Inc. | 2 | $105 |
| Novartis | 4 | $104 |
| Johnson & Johnson Vision Care, Inc. | 1 | $89 |
| Optovue, Inc. | 1 | $87 |
| Bausch & Lomb Americas Inc. | 1 | $55 |
| Oyster Point Pharma, Inc. | 2 | $49 |
| Spark Therapeutics, Inc. | 1 | $37 |
| Sanofi | 1 | $28 |
| Kala Pharmaceuticals, Inc. | 1 | $27 |
| Glaukos Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Izervay$33,339
- CIRRUS HD-OCT$29,500
- FORUM$15,646
- Humphrey HFA$14,114
- CLARUS$13,362
- EYLEA$12,069
- CLARUS 500 Fundus Camera$5,781
- CIRRUS 6000 with AngioPlex$5,750
- CIRRUS 5000 with AngioPlex$5,630
- Humphrey Field Analyzer (HFA3)$4,460
- XOLAIR$3,670
- VisuMax$3,323
- CLARUS 500$2,937
- Glaucoma Workplace$2,760
- CIRRUS AngioPlex$2,000
- Retina Workplace$1,970
- QUATERA 700$1,750
- Syfovre$1,419
- IOLMaster 700$1,123
- FORUM Glaucoma Workplace$690
How this compares
$86,339 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in San Antonio
- Chandler MannSan Antonio$49K
- Jeff FosterSan Antonio$31K
- Melanie FrogozoSan Antonio$21K
- Edward BustamanteSan Antonio$21K
- Arthur MedinaSan Antonio$20K
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Emile FadelAustin$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.